13F HOLDINGS REPORT
Euclidean Capital LLC
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001012975-23-000341
Total Value
$389.1M
Positions
12
Other Managers
0
Confidential Omitted
No
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR S&P 500 ETF TR | SPY | 246,250 | $109.2M | 28.05% |
| 2 | ISHARES TR | 46429B598 | 2,425,144 | $106.0M | 27.23% |
| 3 | SPDR GOLD TR | GLD | 555,000 | $98.9M | 25.43% |
| 4 | 23ANDME HOLDING CO | 90138Q108 | 10,243,122 | $17.9M | 4.61% |
| 5 | PMV PHARMACEUTICALS INC | PMVP | 2,545,242 | $15.9M | 4.09% |
| 6 | FOGHORN THERAPEUTICS INC | FHTX | 1,573,761 | $11.1M | 2.85% |
| 7 | RAPT THERAPEUTICS INC | 75382E109 | 571,233 | $10.7M | 2.75% |
| 8 | ALECTOR INC | ALEC | 980,894 | $5.9M | 1.51% |
| 9 | ORIC PHARMACEUTICALS INC | ORIC | 747,550 | $5.8M | 1.49% |
| 10 | TENAYA THERAPEUTICS INC | TNYA | 915,705 | $5.4M | 1.38% |
| 11 | NGM BIOPHARMACEUTICALS INC | 62921N105 | 746,674 | $1.9M | 0.50% |
| 12 | SURROZEN INC | SRZNW | 802,963 | $441,630 | 0.11% |